Archives
-
Bufalin: From Cardiotonic Steroid to Targeted Degrader
2026-08-18
Bufalin is a cardiotonic steroid with apoptosis-, differentiation-, and protein-degradation activities relevant to modern oncology research. This article presents an assay-centered framework for connecting Bufalin target engagement with STK33 biology, TNBC models, and carefully bounded translational interpretation.
-
E-64 Workflows for Cysteine Protease Research
2026-08-18
E-64 combines irreversible active-site chemistry with broad cysteine protease coverage, making it useful for enzyme kinetics, lysate assays, and pathway validation. This guide translates the reference study into practical workflow choices while showing where broad cathepsin inhibition is informative—and where orthogonal controls are essential.
-
UTP Solution: From RNA Chemistry to Olfactory Assays
2026-08-17
UTP Solution (100 mM) is examined as more than an RNA synthesis reagent: it is a controlled nucleotide input for interpreting transcriptional assays inspired by TRIM66-dependent olfactory receptor regulation. This guide connects reagent quality, assay calibration, RNA workflows, and metabolic context without confusing UTP chemistry with epigenetic mechanism.
-
Catalpol: Practical Workflows for Translational Research
2026-08-17
Catalpol, also indexed as Catalpinoside, supports mechanism-led studies spanning neuroprotection research, bone loss, ischemic injury, fibrosis, and cancer biology. This guide connects concentration and dose selection with pathway-appropriate assays, model-specific controls, and troubleshooting decisions.
-
Clinically Safe Drugs for CRISPR DNA Repair Control
2026-08-16
This Nature Communications study presents a large-scale screen of clinically approved drugs for controlling DNA double-strand break repair after CRISPR editing. By linking sequencing-defined repair outcomes with cell survival, the authors identify pharmacological and genetic routes to alter NHEJ, MMEJ, and HDR, including an ESR2-dependent strategy that improves precise repair and synthetic-lethality opportunities.
-
3-Deazaneplanocin: Context for Translational Oncology
2026-08-15
3-Deazaneplanocin (DZNep) is an SAHH-centered epigenetic modulator that suppresses EZH2-associated H3K27 trimethylation. Its value in translational research lies not only in apoptosis and tumor-sphere assays, but in designing context-aware studies that connect target engagement, cell state, and tissue-specific outcomes.
-
Intravesical p21 mRNA–LNP Therapy in Bladder Cancer
2026-08-14
The reference study develops chemically modified p21 mRNA in lipid nanoparticles as a localized, nonviral tumor suppressor replacement strategy for bladder cancer. Its data link bladder-restricted mRNA expression with cell-cycle inhibition, DNA-damage signaling, apoptosis, and tumor suppression in an orthotopic mouse model, while also defining important translational limitations.
-
2-Thio-dCTP in Chromosome Stability Assays
2026-08-14
Explore how 2-Thio-dCTP can function as a controlled DNA-chemistry perturbation for polymerase, chromatin, and DNA-protein interaction studies. This article connects nucleotide-incorporation design with new mechanistic insights into SCP4-dependent chromosome stability while clearly separating established evidence from experimental opportunity.
-
Gemcitabine HCl in MRI-Guided Cancer Research
2026-08-13
Gemcitabine HCl connects mechanistic DNA replication inhibition with longitudinal tumor measurement in pancreatic cancer models. This workflow combines dose-controlled cytotoxicity testing, MRI-based enrollment, and treatment-response monitoring to improve reproducibility without treating cell-based potency as a substitute for in vivo efficacy.
-
DNA Repair Signals to Translational qPCR
2026-08-13
The expansion of CUX2-positive cortical neurons reveals why mechanistic biology should guide qPCR design. This thought-leadership article translates ATF4-linked DNA repair findings into rigorous SYBR Green workflows for gene expression, RNA-seq validation, and translational nucleic acid quantification.
-
Isoproterenol Sulfate Dihydrate in SAN Models
2026-08-12
Use Isoproterenol sulfate dihydrate as a controlled beta-adrenergic challenge for human SAN-plexus assembloids, from acute pacemaker-rate assays to maturation studies. This workflow separates direct receptor stimulation from neuron-mediated effects, helping researchers interpret cAMP/PKA responses, electrophysiology, and conduction phenotypes with greater precision.
-
PGE2: From Receptor Biology to Translation
2026-08-12
Prostaglandin E2 is more than an inflammation reagent: it is a context-dependent signaling lever that can connect receptor pharmacology, immune regulation, tissue protection, and translational models. This article outlines how to use PGE2 rigorously, interpret complex natural-product findings, and select a research-grade reagent for mechanistic and translational studies.
-
SAN–Cardiac Plexus Assembloids Model Pacemaker Maturation
2026-08-11
The reference study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac plexus, and atrial-like tissues to model neural regulation of pacemaker maturation and impulse conduction. By integrating spatial transcriptomics with functional analysis, the authors identify a CGPO-derived prosaposin–GPR37 signaling program that promotes SAN-like maturation and provides a framework for studying conduction disorders.
-
Isoproterenol Sulfate Dihydrate in Cardiac Assays
2026-08-11
Use Isoproterenol sulfate dihydrate to challenge human SAN-plexus assembloids and resolve beta-adrenergic effects across electrical, biochemical, and maturation readouts. This workflow connects acute GPCR stimulation with the neuro-cardiac architecture described in the reference study, while emphasizing stock preparation, assay controls, and troubleshooting.
-
Human SAN-Plexus Assembloids and Pacemaker Maturation
2026-08-10
The reference study develops human pluripotent stem cell-derived sinoatrial node–cardiac plexus assembloids that reproduce key structural, molecular, and electrophysiological features of neuro-modulated pacemaker activity. By combining assembloid function with spatial transcriptomics of human sinoatrial node tissue, the authors identify a prosaposin–GPR37 signaling program associated with innervation-linked pacemaker maturation and conduction phenotypes.